Biotechnology News

August 4, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE:HTGC) (“Hercules” or the “Company”), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in...

August 4, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kadimastem to collaborate with Merck Serono to advance combined efforts in neurodegenerative disease area

August 4, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Global Blood Therapeutics Names Hing Sham Senior Vice President of Chemistry, Promotes Uma Sinha to Chief Scientific Officer

August 4, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today provided a...

August 4, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Kapa Biosystems has signed a new three-year exclusive distribution agreement with Nippon Genetics Co., Ltd.

August 4, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today reported second quarter and year-to-date 2014 financial results and highlighted recent corporate progress. Recent Corporate...

August 4, 2014

CHANDLER, Ariz.--(BUSINESS WIRE)--Roy Curtiss, III, Ph.D., of the Biodesign Institute at Arizona State University, has been selected as the recipient of the 2014 AZBio Pioneer Award for Lifetime Achievement.

August 4, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq: INSM) today announced that, following discussions with European regulatory authorities, it intends to file by the end of 2014 a Marketing Authorization Application (MAA) with the...

August 4, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Monday, August 11, 2014 at 5:00 PM Eastern Time.

August 4, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--Nanoviricides restarts its Ebola drug development program. Company says its cGMP manufacturing facility can provide sufficient quantities of a drug to combat an ebola epidemic.

August 4, 2014

REHOVOT, Israel--(BUSINESS WIRE)--Evogene announced today that Assaf Kacen, Evogene's Executive Vice President Technology Platform, will present at the Jefferies 2014 Global Industrials Conference on August 11, at 10:30 am

August 4, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical has raised $21.5 million in a private placement offering. The company is discovering and developing novel immunotherapies that help the human immune system attack diseased cells.

August 4, 2014

CHICAGO--(BUSINESS WIRE)--RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, announced today the appointment of Mark Weinberg MD...

August 4, 2014

FRANKFURT & ESCHBORN, Germany--(BUSINESS WIRE)--Accovion announced today a new international structure for its clinical operations designed to facilitate the company's strategic plans for growth throughout Europe. “The implementation of a new...

August 4, 2014

TAINAN, Taiwan--(BUSINESS WIRE)--A total of four teams from National Cheng Kung University (NCKU), southern Taiwan, won big at the competition of Innovation & Startups program initiated by the Ministry of Science and Technology (MOST), the...

August 4, 2014

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIR-B) today announces that it has entered a license agreement with Boehringer Ingelheim International GmbH for exclusive, global rights to a drug program for the treatment and...

August 4, 2014

BOSTON & NEW YORK--(BUSINESS WIRE)--Allied Minds and Bristol-Myers Squibb formed Allied-Bristol Life Sciences, a jointly owned enterprise that will foster pre-clinical development of biopharmaceutical innovations from US universities.

August 3, 2014

TOKYO & ST. LOUIS--(BUSINESS WIRE)--Certara Launches D360 in Japan to Improve Drug Discovery and Development Productivity.

August 1, 2014

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that the Minister of Industry has approved the previously announced proposed acquisition of all the common shares of Nordion Inc. by Sterigenics, pursuant to the...

August 1, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (the “Company, the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related...

August 1, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) will release its financial results for the second quarter ended June 30, 2014, on Thursday, August 7, 2014 at approximately 4:00 p.m. ET / 1:00 p.m. PT. The...

August 1, 2014

HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will announce results of its...

August 1, 2014

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) has officially extended its Call for Papers deadline to August 20, 2014 for the 2014 Pacific Rim Summit on Industrial Biotechnology and Bioenergy.

August 1, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Class action securities litigation has been brought on behalf of purchasers of the securities of Endocyte, Inc. (NasdaqGS:ECYT) between March 21, 2014 and May 2, 2014, inclusive.

August 1, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative company specialized in the development of drugs for orphan oncology...

August 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Lumizyme manufactured at the 4000L scale is now indicated for all Pompe patients of any age or phenotype. The approval of this indication is now consistent with that of the rest of the world.

August 1, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today filed a lawsuit in the United States District Court for the Central District of California against Valeant Pharmaceuticals International, Inc. (“...

August 1, 2014

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), today announced that Pfizer and Roche have joined the ADDPLAN® DF Consortium. The consortium was founded in 2013 by Novartis Pharma AG, Janssen Pharmaceuticals Inc., Eli Lilly, and Aptiv Solutions...

August 1, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Dr. Michael Bookman will join Arizona Oncology, a practice in The US Oncology Network, and serve as medical director of the US Oncology Research Gynecology Research Program.

August 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven’s management team will host a conference call and audio webcast at 8:30 a.m., ET, Wednesday, August 13, 2014 to discuss 2nd quarter 2014 results and recent business developments

August 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS), is proud to announce that Senior Vice President of...

August 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the posting of the management presentation recording from the 2014 Annual Shareholders Meeting held on July 30th, 2014. The recording is available on the...

August 1, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today reported financial results for the three-month period...

August 1, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced that the European Commission has granted orphan drug designation to Soliris for the treatment of patients with Myasthenia Gravis.

August 1, 2014

BETHESDA, Md.--(BUSINESS WIRE)--The Association for Molecular Pathology reaffirmed its position that the vast majority of laboratory developed procedures should continue operating under the regulation of the CLIA program at the CMS

July 31, 2014

LONDON--(BUSINESS WIRE)--The UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated, thanks to a package of investment worth more than £...

July 31, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that John Hodgman, a member of Sarepta’s board of directors, has been named interim chairman,...

July 31, 2014

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth and The Chan Soon-Shiong Institute of Molecular Medicine founder and Chairman Dr. Patrick Soon-Shiong today announced its partnership with Providence Health and Services to create the country’s...

July 31, 2014

WASHINGTON--(BUSINESS WIRE)--USDA’s new methods for measuring changes in greenhouse gas emissions from farming and forestry can help industrial biotech companies establish the environmental benefits of building the bioeconomy. The Biotechnology...

July 31, 2014

EYSINS, Switzerland--(BUSINESS WIRE)--Vertex Receives European Approval for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations

July 31, 2014

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics today announced results for its fiscal 2014 third quarter, and the Company earlier today filed a $175 million universal shelf registration statement with the SEC.

July 31, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq:EXEL) today reported financial results for the quarter ended June 30, 2014. Q2 2014 Highlights and Recent Events Reported positive top-line results from coBRIM, the phase 3...

July 31, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the second quarter ended June 29, 2014. The Company...

July 31, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will Report Fiscal 2014 Third Quarter Financial Results and hold a Conference Call on Tuesday, August 12, 2014

July 31, 2014

CUPERTINO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (OTCQB:AFFY) today reported financial results for the second quarter ending June 30, 2014. The net income for the second quarter of 2014 was $7.2 million (or $0.19 per share) compared to net...

July 31, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the second quarter and six months ended June 30, 2014. The company also highlighted ADCETRIS (brentuximab vedotin) commercialization and...

July 31, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the second quarter ended June 30, 2014.

July 31, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) today announced financial results for the second quarter ended June 30, 2014. “First half results were in-line with our expectations and reflect the impact of strategic changes in...

July 31, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the second quarter ending June 30, 2014 on Thursday, August 7, 2014,...